The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Sox4 Oncogene Potential Target In Acute Myeloid Leukemia
The Sox4 oncogene may be a potential therapeutic target in the treatment of acute myeloid leukemia.
Toshiba, TOMODACHI Launch Science & Tech Leadership Academy
Toshiba and TOMODACHI have launched a science and tech leadership academy to invest in the next generation of Japanese and American leaders.
Ginger-Shaped Asteroid Glides By China’s Lunar Probe Chang’e-2
A close flyby by Chang’e-2 of the near-Earth asteroid 4179 Toutatis reveals new insights into the geological features and formation of the ginger-root-shaped asteroid.
Silkworms That Spin Colorful Silk Fibers
Scientists have discovered a 'greener' dyeing method to producing colorful silk: by feeding dyed leaves to silkworms so they spin colored - rather than white - cocoons.
India’s Blood Pressure Skyrockets
Hypertension is skyrocketing in India, with rural-to-urban migrants at especially high risk.
Taiwanese Study Shows Gout To Be Genetic
A study on the entire Taiwanese population of 23 million has confirmed that gout strongly runs in families.
Recycled Plastic Finds New Role In Killing Drug-Resistant Fungi
Researchers have discovered a new, potentially life-saving application for polyethylene terephthalate, which is widely used to make plastic bottles.
CAS Researcher Wins Agilent Thought Leader Award
Researcher Dr. Junying Yuan has won the Agilent Thought Leader Award in recognition of her research into neurodegenerative diseases.
Oral Proteasome Inhibitor Could Improve Multiple Myeloma Treatment
Takeda has announced clinical study results combining oral investigational MLN9708 with lenalidomide and dexamethasone, in patients with newly diagnosed multiple myeloma.